10-K: Altria Group, Inc. Files 10-K Report, Details Financials and Strategic Initiatives

Altria Group, Inc. releases its annual 10-K report, outlining its financial performance, strategic initiatives, and risk factors for the fiscal year ended December 31, 2023.

Summary

• Altria Group, Inc. has filed its annual report on Form 10-K for the year ended December 31, 2023.
• The report details the company's financial performance, strategic initiatives, and risk factors.
• Altria's vision is to lead the transition of adult smokers to a smoke-free future.
• The company's wholly-owned subsidiaries include Philip Morris USA, John Middleton Co., UST LLC, Helix Innovations LLC, and NJOY, LLC.
• Altria completed the acquisition of NJOY Holdings, Inc. for approximately $2.9 billion on June 1, 2023.
• In March 2023, Altria transferred its JUUL equity securities in exchange for a non-exclusive, irrevocable global license to certain of JUUL's heated tobacco intellectual property.
• The company's reportable segments are smokeable products and oral tobacco products.
• Total smokeable products segment cigarette shipment volume in the United States was 76.3 billion units in 2023, a decrease of 9.9% from 2022.
• Total smokeable products segment cigar shipment volume was approximately 1.8 billion units in 2023, an increase of 2.8% from 2022.
• Total oral tobacco products segment shipment volume was 782.9 million units in 2023, a decrease of 2.2% from 2022.
• The company's adjusted diluted EPS for 2023 was $4.95, compared to $4.84 in 2022.
• Altria has a progressive dividend goal targeting mid-single digits dividend per share growth annually through 2028.
• The company completed a $1.0 billion share repurchase program in December 2023 and authorized a new $1.0 billion program in January 2024.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While there are positive aspects such as the NJOY acquisition and strategic initiatives, the decline in traditional product volumes and the presence of significant risks temper the overall outlook. The sentiment is neutral to slightly negative.

Positives

• Altria's adjusted diluted EPS increased year-over-year.
• The company completed the strategic acquisition of NJOY, expanding its presence in the e-vapor market.
• Altria secured a global license to certain of JUUL's heated tobacco intellectual property.
• The company has a progressive dividend goal targeting mid-single digits dividend per share growth annually through 2028.
• Altria completed a $1.0 billion share repurchase program and authorized a new one for the same amount.

Negatives

• Cigarette shipment volume decreased by 9.9% in 2023.
• Oral tobacco products shipment volume decreased by 2.2% in 2023.
• The company faces significant competition and regulatory challenges.
• Altria may be unsuccessful in commercializing innovative products.
• The company may be required to write down intangible assets due to impairment.

Risks

• Altria may be unsuccessful in anticipating and responding to changes in adult tobacco consumer preferences.
• The company faces significant competition, and failure to compete effectively could have a material adverse effect.
• Altria may be unsuccessful in commercializing innovative products, including tobacco products with reduced health risks.
• Failure to complete or manage strategic transactions could have a material adverse effect.
• Significant changes in price, availability or quality of tobacco, other raw materials or component parts could have a material adverse effect.
• Unfavorable outcomes with respect to litigation proceedings or any governmental investigations could materially adversely affect the company.
• Significant federal, state and local governmental actions, including FDA regulatory actions and inaction, may continue to have a material adverse impact.
• Increases in tobacco product-related taxes could have a material adverse impact on sales.
• Disruption and uncertainty in the credit and capital markets could materially adversely affect the business.
• The failure of information systems to function as intended, or cyber-attacks or security breaches, could have a material adverse effect.

Future Outlook

Altria aims to deliver a mid-single digits adjusted diluted EPS compounded annual growth rate in 2028 from a $4.84 base in 2022, a progressive dividend goal targeting mid-single digits dividend per share growth annually through 2028, and to grow U.S. smoke-free volumes by at least 35% from a 2022 base by 2028.

Management Comments

• Altria's vision is to responsibly lead the transition of adult smokers to a smoke-free future.
• We are Moving Beyond Smoking TM , leading the way in moving adult smokers away from cigarettes by taking action to transition millions to potentially less harmful choices believing it is a substantial opportunity for adult tobacco consumers, our businesses and society.

Industry Context

The announcement reflects the ongoing shift in the tobacco industry towards smoke-free alternatives and the challenges posed by regulatory pressures and changing consumer preferences. Altria's strategic moves, such as the acquisition of NJOY and the licensing agreement with JUUL, indicate its efforts to adapt to these trends and compete in the evolving market.

Comparison to Industry Standards

• Altria's cigarette volume decline of 9.9% is significant, reflecting a broader trend in the industry, but also highlighting the challenges faced by traditional tobacco companies.
• The growth in the e-vapor category, driven by illicit flavored disposable products, is a trend impacting all players in the market, and Altria's NJOY acquisition is a direct response to this.
• The company's focus on smoke-free products and its 2028 goals align with the industry's move towards harm reduction and alternative nicotine delivery systems, similar to strategies adopted by Philip Morris International and British American Tobacco.
• Altria's financial metrics, such as adjusted EPS and OCI margins, are key indicators of its performance compared to its peers in the tobacco and consumer goods sectors.
• The company's debt-to-Consolidated EBITDA target of approximately 2.0x is a common benchmark used in the industry to assess financial health and leverage.

Management Changes

Legal Proceedings

• The company is involved in various legal proceedings, including product liability, unfair trade practices, antitrust, tax, contraband-related claims, patent infringement, employment matters, and claims alleging violations of RICO.
• Altria is subject to ongoing litigation related to its former investment in JUUL.
• The company is involved in various patent infringement lawsuits related to its e-vapor and heated tobacco products.
• Altria is subject to various governmental investigations.

Stakeholder Impact

• Shareholders may be impacted by the company's financial performance, dividend policy, and share repurchase programs.
• Employees may be impacted by the company's human capital resources policies and compensation and benefits programs.
• Customers may be impacted by changes in product offerings and pricing.
• Suppliers may be impacted by changes in the company's supply chain and sourcing strategies.
• Creditors may be impacted by the company's debt levels and credit ratings.

Next Steps

• The company expects to complete a $1.0 billion share repurchase program by December 31, 2024.
• Altria will continue to monitor the evolving macroeconomic and geopolitical landscapes.
• The company will continue to engage with the FDA and other government agencies.
• Altria will continue to evaluate the potential impacts of trends and developments on its business, investments and Vision.

Key Dates

Keywords

tobacco, cigarettes, e-vapor, oral nicotine pouches, smokeless tobacco, NJOY, JUUL, FDA, regulation, litigation, financial results, share repurchase, dividends, strategic transactions